Cancer Nursing Today

✨ As we count down to the conclusion of CARE Award voting, we're shining a spotlight on each of our finalists! ⭐ Today, we're introducing you to Deana DiMichele, RN, BSN, OCN, who is an oncology-certified level 3 nurse in infusion at the Rush Cancer Institute. She provides patient care and works as the unit charge nurse and unit preceptor for new staff. Deana has worked in oncology for over 10 years, becoming a nurse after her father passed away from stage IV colorectal cancer. 📺 Watch her finalist video: https://buff.ly/3AARWAZ #nursing

The U.S. Food and Drug Administration has approved subcutaneous daratumumab and hyaluronidase-fihj (DARZALEX FASPRO) in combination with bortezomib, lenalidomide, and dexamethasone for induction and consolidation in patients with newly diagnosed multiple myeloma who are eligible for an autologous stem cell transplant, according to an announcement from Johnson & Johnson. Read more: https://lnkd.in/gJYBRGGe

Did you know that patients with musculoskeletal system chronic GVHD can have both typical and atypical manifestations, and that some of the atypical symptoms may not be recognized as being caused by GVHD? In this new article, our contributor Elaine S. DeMeyer, RN, MSN, AOCN, BMTCN, shares how oncology nurses can overcome the challenges associated with recognizing and managing musculoskeletal system chronic GVHD. Read here: https://lnkd.in/ghNPbVU3 #GVHD #bmtsm #oncology #nursing

📆 Did you know that CARE Award voting closes next weekend? Don't miss your chance to vote and meet our amazing group of CARE Award finalists: 🌟Michelle Ranaghan, MSN, RN, CRNI, OCN, of Dana-Farber Cancer Institute 🌟Jennifer Margolis, BSN, RN, OCN, BMTCN, of Rush University Medical Center 🌟Dr. Wendy Garvin Mayo, DNP, APRN, ANP-BC, of Collaborative Cancer Care 🌟Deana DiMichele, RN, BSN, OCN, of Rush MD Anderson Cancer Center ➡ Learn more about our finalists through their video introductions, bios, and words from their nominators: https://lnkd.in/eFav9uxB

📋 Can ROCK2 inhibitors play a role treating ocular GVHD? 📰 A team from the University of Maryland Medical Center published research in the Association for Research in Vision and Ophthalmology (ARVO)'s Investigative Ophthalmology & Visual Science journal that addressed the question. ➡️ Learn more: https://buff.ly/3YTndJt #GVHD #bmtsm

📆 Only 10 more days left to vote for a CARE Award finalist! ➡️ Meet our finalists and vote here today: https://buff.ly/3AxpmQS #CAREaward2024 #CancerNursesCARE

📰 Keeping up with all the regulatory approvals in oncology lately? 📺 Don't miss this new video interview with Amrita Krishnan, MD, Director of the Judy and Bernard Briskin Multiple Myeloma Center at the City of Hope, who shares her insights on the recent approval of a quadruplet therapy for patients with multiple myeloma who are eligible for ASCT and what nurses need to know. ➡ Watch here: https://lnkd.in/gTYtYySS #nursing #oncology #FDA #mmsm #myeloma

New from Cancer Nursing Today: Explore key nursing highlights from summer conferences and meet the CARE Award Finalists. Place your vote by August 31 to help determine the winner! https://lnkd.in/dXGifsaS

🤔 How is August already more than halfway over? 🍂 We can't believe how fast the summer has flown by, but we're gearing up for an exciting fall conference season, and the announcement of our CARE Award winner in September! ➡ If you're planning out your fall, check out our calendar for key oncology nursing events: https://lnkd.in/eBACVhZf

🌞 Looking for some great reading this weekend? ✅ Meet our amazing group of CARE Award finalists, hear their stories, and submit your vote! ⏰ Don't miss your chance - voting is open for a limited time! ➡️ Learn more and vote here: https://buff.ly/3LeddlD #CAREaward2024 #CancerNursesCARE